After-hours movers:
lululemon athletica (NASDAQ: LULU ) fell 6% after it issued full year guidance that trailed estimates, despite beating estimates for fourth quarter EPS and revenue.
Argan (NYSE: AGX ) rose 13% after its quarterly EPS and revenue beat consensus. Argan reported Q4 EPS of $2.22, $1.07 better than the analyst estimate of $1.15. Revenue for the quarter came in at $232.47 million versus the consensus estimate of $197.5 million.
Portage Biotech (PRTG) rose 30% after reporting promising preclinical results in mesothelioma supporting the first-in-human trial of PORT-7.